spmT WB GroupXDrug BDD>HC

Contributed by sallygrace on March 26, 2018

Collection: Intranasal oxytocin alters amygdala-temporal resting-state functional connectivity in body dysmorphic disorder: A double-blind placebo-controlled randomized trial

Description: SPM{T_[416.0]} - contrast 3: Group x Drug: BDD greater in Oxyt

3D View
Warning: This map is missing some mandatory metadata!
Field Value
Citation guidelines

If you use these data please include the following persistent identifier in the text of your manuscript:


This will help to track the use of this data in the literature. In addition, consider also citing the paper related to this collection.